CellaVision AB (publ) (STO:CEVI)
180.00
-1.40 (-0.77%)
Oct 31, 2025, 12:59 PM CET
CellaVision AB Revenue
CellaVision AB had revenue of 191.33M SEK in the quarter ending June 30, 2025, with 1.88% growth. This brings the company's revenue in the last twelve months to 751.47M, up 3.45% year-over-year. In the year 2024, CellaVision AB had annual revenue of 723.22M with 6.78% growth.
Revenue (ttm)
751.47M
Revenue Growth
+3.45%
P/S Ratio
5.71
Revenue / Employee
3.28M
Employees
219
Market Cap
4.29B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 723.22M | 45.93M | 6.78% |
| Dec 31, 2023 | 677.29M | 37.95M | 5.94% |
| Dec 31, 2022 | 639.34M | 73.79M | 13.05% |
| Dec 31, 2021 | 565.55M | 94.11M | 19.96% |
| Dec 31, 2020 | 471.44M | 9.67M | 2.09% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Getinge AB | 35.85B |
| Swedish Orphan Biovitrum AB | 27.85B |
| Medicover AB | 25.22B |
| Elekta AB | 17.84B |
| Asker Healthcare Group AB | 15.88B |
| AddLife AB | 10.53B |
| Nolato AB | 9.57B |
| Vitrolife AB | 3.51B |
CellaVision AB News
- 9 months ago - CellaVision AB (CLVSF) Q4 2024 Earnings Call Highlights: Record APAC Sales and Strategic Growth ... - GuruFocus
- 9 months ago - Q4 2024 CellaVision AB Earnings Call Transcript - GuruFocus
- 1 year ago - Q3 2024 CellaVision AB Earnings Call Transcript - GuruFocus
- 5 years ago - 3 Scandinavian Companies With Strong Margin Growth - GuruFocus